Status:
COMPLETED
Visualization of Carotid Atherosclerosis by 68Ga-MSA
Lead Sponsor:
Korea University
Collaborating Sponsors:
SHIN JIN MEDICS
Conditions:
Atherosclerosis
Carotid Atherosclerosis
Eligibility:
All Genders
Phase:
PHASE1
Brief Summary
Until now, no specific atherosclerosis-targeting agent labeled with positron emitter is not yet available. Investigators developed neomannosyl human serum albumin(MSA) for the terminal mannose residue...
Eligibility Criteria
Inclusion
- •coronary artery disease patients with carotid plaques
- control without carotid plaque
Exclusion
- •pregnancy, allergy to albumin, any acute or chronic inflammatory disease, hematologic disease, liver disease, renal disease
Key Trial Info
Start Date :
September 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01893489
Start Date
September 1 2012
End Date
August 1 2013
Last Update
August 27 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nuclear Medicine, Institute of Radiation Medicine,
Seoul, South Korea, 110-744
2
Korea University Guro Hospital
Seoul, South Korea, 152-703